Chief Executive Officer (CEO)
Pascal Prigent has a rich experience of more than 20 years in the pharmaceutical industry (Eli Lilly, GSK), on 3 continents (Europe, North America, Latin America). Prior to joining GENFIT, he was Vice President Marketing for the Vaccines division of GSK US where he led the commercial strategy for a multi-billion dollar vaccine portfolio. Pascal Prigent holds a Master of Business Administration from INSEAD (1995) and is a graduate of Reims Business School (1989). Pascal is GENFIT’s CEO, effective on September 16, 2019.
Chief Operating Officer (COO)
Dean Hum earned a Ph.D. in Biochemistry from McGill University in Montreal in 1990. An expert in the modulation of transcription factors and nuclear receptors associated with endocrine and cardiometabolic diseases, he held a research position at the University of California in San Francisco before becoming a Professor at Laval University in Quebec. He joined GENFIT in 2000 as Chief Scientific Officer. Dean Hum is today a key person in the organization of GENFIT. In particular, he is responsible for defining, implementing, employing and coordinating short-, medium- and long-term strategies relating to R&D programs and portfolio. He coordinates all R&D activities with the CEO and in close collaboration with scientific officers and project managers.
Executive VP and Chief Financial and Administrative Officer (CFO)
Nathalie Huitorel is a graduate of the SKEMA Business School (School of Management in Lille, France). For 10 years she was Chief Financial and Administrative Officer for MS COMPOSITES, a company specializing in high-performance composite materials. She took part in listing a subsidiary of the French company FINUCHEM on the Stock Exchange and has led numerous mergers and acquisitions. She was appointed Chief Financial and Administrative Officer at GENFIT in October 2007, and oversees the accounting, management and human resources departments.
Chief Medical Officer
Carol Addy has over 30 years working in the healthcare and wellness space, including leading clinical development teams in the pharmaceutical industry (Merck) and supporting life-cycle management of approved therapies for obesity. Prior to joining GENFIT, she was Chief Medical Officer at HMR Weight Management Services Corp., a wholly owned subsidiary of Merck. Carol Addy holds an M.D. degree from the University of Massachusetts Medical School and a Masters of Medical Science degree from Harvard Medical School. Carol is GENFIT’s CMO, effective on September 2, 2019.
Chief Strategy Officer
Jean-Christophe Marcoux is an engineer, and graduated from INSA Lyon in France, having spent part of his time at the University of Leeds in England, and also holds a degree in Strategic Management and Economic Intelligence from EGE in France. For nearly 15 years, he led international projects and programs in a variety of industrial sectors, in particular in Europe and Asia, and with client and colleagues in the United States. In 2012, he joined IMS Health, now Quintiles IMS, the leading global information and technology services company providing clients in the healthcare industry, where he lead projects in healthcare systems: patient longitudinal studies, forecasting, targeting, profiling, prospective analyses, digital healthcare and innovation. He joined GENFIT at the end of 2015 to play a cross-disciplinary role regarding tactical, strategic and operational matters and was named Chief Strategy Officer at the end of 2016. He is also Corporate Secretary of The NASH Education Program TM , the endowment fund created by GENFIT at the end of 2016.
Head of Global Diagnostics
Corporate Secretary, Director of Legal Affairs
Laurent Lannoo graduated from the University of Lille law school with a degree in Business Law (DESS Juriste d’Entreprise ). He began his professional career at M&M, a consulting firm, in 1994, becoming partner in 1996. One of the consulting projects led him to join Eurasanté, the public agency for the economic development of healthcare activities in the Nord – Pas de Calais region of France in 1995, where he was in charge of finance and administration (20 employees). Thereafter, he was the Corporate Secretary of the Cœur et Artères foundation and chairman of its executive board from 2005 to 2008. In 2008, he joined GENFIT as Corporate Secretary and Director of Legal Affairs.